Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00612040

Femme et Homme

Extrait

This trial is conducted in Europe, Oceania and the United States of America (USA). The aim of this trial is to compare two NN1250 (insulin degludec) formulations with each other and with insulin glargine, all in combination with insulin aspart in subjects with type 1 diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1


Liens